How Top Medical Device Companies Use AlphaSense
The medical device industry is the booming fast-growing sub-sector of the medical technology (medtech) industry. While this industry has been around for decades, the 2020 global pandemic proved to be a catalyst for accelerated growth in this space—a trend that is only expected to continue into the foreseeable future.
The medical device industry has proven to be one of the most opportunistic—capable of improving patient outcomes worldwide and transforming the healthcare system as we know it—with increased demand from investors. It’s also constantly expanding, as new entrants and innovations are entering the space at a rapid clip.
That’s why it’s never been more important for medical device companies to have an airtight market research process and a proactive strategy. Without the right tool, the task of parsing through vast quantities of data, locating the right insights, and then analyzing and implementing those insights becomes herculean. Moreover, manual market research dramatically slows you down and leaves you vulnerable to human error and missed insights.
AlphaSense not only helps you stay informed on the critical insights that matter most, but empowers you to apply those insights towards specific strategic goals, go-to-market motions and commercialization tactics. Our platform speeds up your time to insight so you can increase research confidence and be more proactive in strategy-building.
Here’s how our medtech and medical device clients use AlphaSense to succeed:
AlphaSense surfaces all the competitive insights you need so that you can benchmark against peers, find out about any emerging competitors or technologies, generate ideas for new product development, and identify competitive risks—all in one place.
You can receive real-time alerts for 510(k) filings, competitors’ earnings reports, topical broker research, and expert call transcripts. And with our company recognition and Search Summaries features, you will always be first to know about any competitor updates, such as launches and recalls of new devices, technologies, or treatment methods.
Corporate Development and M&A
AlphaSense allows you to get smart on an investment target, emerging technology, intellectual property, or competitive landscape by using AI to find insights faster. Our natural language processing (NLP) feature, theme extraction, enables you to spot interesting assets within the noise by uncovering financial metrics beyond those found in standard 10-Ks or 10-Qs.
Theme extraction allows you to see how incumbent companies are conducting their M&A strategy, including what types of companies are getting acquired or who they are funded by, as well as how large healthcare firms are approaching their investments in smaller medtech companies.
This feature is critical in this space because new companies, technologies, and devices are constantly emerging, and having access to a tool like AlphaSense keeps you in-the-know— without the information overload.
You can also use AlphaSense to gain intel on private companies. Instantly access funding round information, acquisition history, public comps, and peer comparison charts—without digging through multiple, potentially fruitless, sources.
AlphaSense also makes it simple to monitor specific subsectors of the medtech industry by searching those topics on the platform and seeing how the keywords have trended over time.
For instance, if you are interested in the TAM and growth outlooks for cardiovascular devices, you can uncover key insights such as: the U.S. forecast for adults with heart disease, current existing treatments and new diagnostic technologies for cardiovascular health, the main players in the cardiovascular medtech space, how much healthcare systems have invested already in cardiovascular medical equipment, and so on, by simply searching “cardiovascular” AND “medical devices” and filtering for each content set in our platform.
If you are interested in commercializing a product, device, or technology, AlphaSense can help you extract market data from qualitative sources to develop TAM analyses, evaluate market opportunities to forecast sales, and develop go-to market strategies.
AlphaSense also allows you to find answers to key questions during commercialization:
- Is the concept novel and validated? To answer this, you need to evaluate the market landscape—what kinds of companies are in this space, what technologies are being used, what are the health systems using this tech, what other companies have tried bringing a similar product to market in the past, and what do experts and doctors say about similar devices or technologies?
- Has the concept cleared the regulatory and FDA requirements? For this, you can consult regulatory documents such as 510(k) filings, FDA statements, and European Medicines Agency documents, all housed on the AlphaSense platform.
- Is your product faster, better, or more cost-effective than competitors’? For this, you can rely on competitive signals and M&A tracking, so you can always be aware of key factors such as a huge incumbent adding a similar company to its portfolio, health system/consumer spending in a potential target market, and what pricing and profitability look like for similar technology.
One important consideration in commercialization is the possibility of partnering with a biopharma company or health system in order to lower cost or expand reach. For this, you must have a tool that enables you to conduct in-depth research on public and private companies.
Finally, successful commercialization involves finding reliable manufacturing and distribution partners. AlphaSense can help uncover who is currently making similar devices, how they are shipped, and what geographic regions are best to target with the supply chain.
Accelerate Your Medical Device Research Process With AlphaSense
AlphaSense aggregates all the essential market research perspectives you need in one place, so you can have a complete picture of the company profiles, markets, or trends you are researching.
Combined with proprietary AI and automation functionality not found on other platforms, AlphaSense helps you dramatically increase the breadth, depth, and accuracy of your research.
Here’s what you get when you use the AlphaSense platform for your market intelligence:
Aggregated Market Research
AlphaSense houses a vast universe of over 10,000 trusted content sources, including but not limited to:
- Company documents such as event transcripts, global filings, press releases, company presentations, product brochures, and ESG reports, in addition to private company documents
- Industry research from the world’s top financial research firms, including Cowen, Morgan Stanley, Bank of America, Jefferies, and JP Morgan, as well as our proprietary equity research content set Wall Street Insights that is specifically tailored for corporate clients
- Unique industry expert perspectives from customers, competitors, medical experts, doctors, and partners
- Thousands of curated news sources, trade publications, and regulatory information such as 510(k)s
Our platform not only houses all of the content you need to make rapid data-driven decisions, it also helps you cut through the noise with advanced search functionality.
Instead of digging through fragmented reports and alerts, you can rely on our semantic search to ensure you never miss out on critical insights. Our AI search technology automatically recognizes what you are looking for and delivers the results that match the intent behind your query. This means you don’t have to do multiple searches to get the results you need, and you can be more confident in the comprehensiveness and accuracy of your research.
With AlphaSense, you can use AI-based sentiment analysis to identify, quantify, and analyze levels of emotion within text, particularly earnings calls and expert transcripts. Understanding sentiment can help you catch the subtle inflection points in language that move markets and provide early indicators of shifting corporate performance. This feature works in seconds, saving hours previously spent combing through company documents and expert transcripts for the best insights.
Unlike other generative AI (genAI) tools that are focused on consumer users and trained on publicly available content across the web, AlphaSense takes an entirely different approach. As a platform purpose-built to drive the world’s biggest business and financial decisions, our Smart Summaries feature leverages our 10+ years of AI tech development and draws from a curated collection of high-quality business content.
With Smart Summaries, you can glean instant earnings insights—reducing time spent on research during earnings season, quickly capture company outlook, and generate an expert-approved SWOT analysis straight from former competitors, partners, and employees. Additionally, all sources are cited, so you can verify any information by simply consulting the source documents.
Medical Device Insights From the AlphaSense Platform
We pull from our database of expert call transcripts to uncover the top trending medtech topics, as discussed by medical professionals and industry leaders.
We use our platform to identify the most lucrative M&A opportunities in the medtech space, based on products, growths, and margins.
We use our platform’s vast content database—including equity research, earnings transcripts, news, and expert calls—to identify the top themes and topics in the medtech space that are trending quarter over quarter.
Read about how a Fortune 500 medical device leader uses AlphaSense to increase efficiency in their market research and analysis process.